Zabdeno

Zabdeno is an Ebola vaccine containing an adenovirus viral vector designed to help prevent Ebola virus disease. This non-replicating vaccine is administered via intramuscular injection. It is intended for use in individuals at risk of exposure to the Ebola virus. Store as directed by healthcare guidelines.

Zabdeno is used to help prevent Ebola virus disease caused by the Ebola Zaire strain. It is indicated for individuals who may be at risk due to travel, occupational exposure, or outbreak situations. The vaccine works by prompting the immune system to produce antibodies against the virus. It is not a treatment for active infections.

After vaccination with Zabdeno, some individuals may experience mild to moderate effects such as pain or redness at the injection site. General effects like fatigue, headache, or muscle pain may also occur. These effects are typically temporary and resolve within a few days.

Zabdeno should be handled and administered by trained healthcare professionals. Individuals with severe allergies to any component of the vaccine should avoid use. Pregnant or breastfeeding individuals should consult a healthcare provider before vaccination. Always disclose your medical history to your provider.

Zabdeno may interact with immunosuppressive therapies or other vaccines. Avoid receiving other vaccines simultaneously unless directed by a healthcare provider. Inform your provider about all medications and treatments you are currently using.